Form 4 Tracker
Jula Inrig

CHIEF MEDICAL OFFICER; EVP, Head of R&D & CMO · 6 filings · Latest: Sep 15, 2026

Travere Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
TVTX
Jula InrigEVP, Head of R&D & CMOSep 15, 2026
Sale
$62.3444,674$2.8M100,491
TVTX
Jula InrigEVP, Head of R&D & CMOSep 15, 2026
Option Exercise
$8.9332,395$289.3K145,165
TVTX
JULA INRIG—Sep 15, 2026
Proposed Sale
$65.7944,674$2.9M—
TVTX
Jula InrigCHIEF MEDICAL OFFICERMay 6, 2026
Sale
$43.95311$13.7K113,238
TVTX
Jula InrigCHIEF MEDICAL OFFICERMay 5, 2026
Sale
$46.652,174$101.4K113,549
TVTX
Jula InrigCHIEF MEDICAL OFFICERMay 4, 2026
Sale
$45.0020,000$900.0K111,473
TVTX
Jula InrigCHIEF MEDICAL OFFICERMay 4, 2026
Option Exercise
$18.4724,250$448.0K115,723
TVTX
JULA INRIG—May 6, 2026
Proposed Sale
$43.95311$13.7K—
TVTX
Jula Inrig—May 5, 2026
Proposed Sale
$46.652,174$101.4K—
TVTX
JULA INRIG—May 4, 2026
Proposed Sale
$45.0020,000$900.0K—
TVTX
Jula InrigCHIEF MEDICAL OFFICERApr 15, 2026
Sale
$42.611,018$43.4K111,473
TVTX
Jula InrigCHIEF MEDICAL OFFICERApr 14, 2026
Sale
$41.937,215$302.5K112,491
TVTX
JULA INRIG—Apr 15, 2026
Proposed Sale
$42.611,018$43.4K—
TVTX
Jula Inrig—Apr 14, 2026
Proposed Sale
$41.937,215$302.5K—
TVTX
Jula InrigCHIEF MEDICAL OFFICERFeb 4, 2026
Sale
$32.211,779$57.3K105,706
TVTX
JULA INRIG—Feb 4, 2026
Proposed Sale
$32.211,779$57.3K—
TVTX
Jula Inrig—Feb 3, 2026
Proposed Sale
$32.126,956$223.4K—
TVTX
Jula InrigCHIEF MEDICAL OFFICERFeb 3, 2026
Sale
$32.126,956$223.4K107,485
TVTX
JULA INRIG—Jan 6, 2026
Proposed Sale
$37.75445$16.8K—
TVTX
Jula Inrig—Jan 5, 2026
Proposed Sale
$40.182,031$81.6K—

Page 1 of 2

Next →